What is Bicara Therapeutics's federal?

Bicara Therapeutics (BCAX) reported federal of $0 in Q4 2025.

What does federal mean?

This metric reflects the current federal income tax expense or benefit recognized in the income statement for the reporting period. It represents the amount of income taxes payable to or refundable from the federal government based on taxable income. It is a key component in understanding the company's immediate federal tax obligations.

Bicara Therapeutics BCAX Federal

Federal at other companies

TFS FinancialTFSL

$5.12M+25.3%

Simmons First NationalSFNC

$2.43M-48.9%

Rackspace Technology, Inc.RXT

-$2.93M-11,600%

Hillman Solutions Corp.HLMN

$538K-62.2%

ESN

Essent GroupESNT

$19.75M-9.7%

V2XVVX

-$32.5K+98.7%

Other financials

Income statement

See full

Operating income-$60.2M-44.2%

Net income-$56.2M-52.6%

EPS (diluted)-$0.93-36.8%

Balance sheet

See full

Cash & equivalents$323.5M-30.0%

Total debt$1.4M+144%

Total equity$514.0M+12.0%

Total assets$553.6M+15.8%

Cash flow

See full

Operating cash flow-$37.5M-33.5%

CapEx$60.0K—

Free cash flow-$37.6M-33.7%

Valuation

See full

Market cap$1.68B+81.4%

Returns & leverage

See full

Return on equity-32.3%—

Debt / equity0×0.0×

Current ratio13.9×-10.8×

Where this comes from

Reported directly by Bicara Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:CurrentFederalTaxExpenseBenefit.

The official record: Bicara Therapeutics’s 10-K, filed March 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bicara Therapeutics's federal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bicara Therapeutics's federal?: Bicara Therapeutics (BCAX) reported federal of $0 in Q4 2025.
What does federal mean?: This metric reflects the current federal income tax expense or benefit recognized in the income statement for the reporting period. It represents the amount of income taxes payable to or refundable from the federal government based on taxable income. It is a key component in understanding the company's immediate federal tax obligations.